These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15832499)

  • 1. Increased acyclovir oral bioavailability via a bile acid conjugate.
    Tolle-Sander S; Lentz KA; Maeda DY; Coop A; Polli JE
    Mol Pharm; 2004 Jan; 1(1):40-8. PubMed ID: 15832499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vitro evaluation of gabapentin prodrugs that target the human apical sodium-dependent bile acid transporter (hASBT).
    Rais R; Fletcher S; Polli JE
    J Pharm Sci; 2011 Mar; 100(3):1184-95. PubMed ID: 20848648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of native bile acids with human apical sodium-dependent bile acid transporter (hASBT): influence of steroidal hydroxylation pattern and C-24 conjugation.
    Balakrishnan A; Wring SA; Polli JE
    Pharm Res; 2006 Jul; 23(7):1451-9. PubMed ID: 16783481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apical sodium dependent bile acid transporter (ASBT, SLC10A2): a potential prodrug target.
    Balakrishnan A; Polli JE
    Mol Pharm; 2006; 3(3):223-30. PubMed ID: 16749855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted lipid based drug conjugates: a novel strategy for drug delivery.
    Vadlapudi AD; Vadlapatla RK; Kwatra D; Earla R; Samanta SK; Pal D; Mitra AK
    Int J Pharm; 2012 Sep; 434(1-2):315-24. PubMed ID: 22692074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of stably transfected monolayer overexpressing the human apical sodium-dependent bile acid transporter (hASBT).
    Balakrishnan A; Sussman DJ; Polli JE
    Pharm Res; 2005 Aug; 22(8):1269-80. PubMed ID: 16078136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of charge and steric bulk in the C-24 region on the interaction of bile acids with human apical sodium-dependent bile acid transporter.
    Balakrishnan A; Wring SA; Coop A; Polli JE
    Mol Pharm; 2006; 3(3):282-92. PubMed ID: 16749860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue.
    Gupta D; Varghese Gupta S; Dahan A; Tsume Y; Hilfinger J; Lee KD; Amidon GL
    Mol Pharm; 2013 Feb; 10(2):512-22. PubMed ID: 23244438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, metabolism and cellular permeability of enzymatically stable dipeptide prodrugs of acyclovir.
    Talluri RS; Samanta SK; Gaudana R; Mitra AK
    Int J Pharm; 2008 Sep; 361(1-2):118-24. PubMed ID: 18573320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural determinants for transport across the intestinal bile acid transporter using C-24 bile acid conjugates.
    Rais R; Acharya C; Mackerell AD; Polli JE
    Mol Pharm; 2010 Dec; 7(6):2240-54. PubMed ID: 20939504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter.
    Han HK; Oh DM; Amidon GL
    Pharm Res; 1998 Sep; 15(9):1382-6. PubMed ID: 9755889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural requirements of the human sodium-dependent bile acid transporter (hASBT): role of 3- and 7-OH moieties on binding and translocation of bile acids.
    González PM; Lagos CF; Ward WC; Polli JE
    Mol Pharm; 2014 Feb; 11(2):588-98. PubMed ID: 24328955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acyclovir prodrug for the intestinal di/tri-peptide transporter PEPT1: comparison of in vivo bioavailability in rats and transport in Caco-2 cells.
    Thomsen AE; Christensen MS; Bagger MA; Steffansen B
    Eur J Pharm Sci; 2004 Dec; 23(4-5):319-25. PubMed ID: 15567284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel cascade strategy using a nanonized targeted prodrug for enhanced oral delivery efficiency.
    Guo M; Yu S; Huang Y; Song H; Li M; Liu D; Fu Q; He Z
    Int J Pharm; 2020 Sep; 587():119638. PubMed ID: 32659406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter.
    Han H; de Vrueh RL; Rhie JK; Covitz KM; Smith PL; Lee CP; Oh DM; Sadée W; Amidon GL
    Pharm Res; 1998 Aug; 15(8):1154-9. PubMed ID: 9706043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carrier-mediated intestinal absorption of valacyclovir, the L-valyl ester prodrug of acyclovir: 1. Interactions with peptides, organic anions and organic cations in rats.
    Sinko PJ; Balimane PV
    Biopharm Drug Dispos; 1998 May; 19(4):209-17. PubMed ID: 9604120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of amino acid ester prodrugs of acyclovir after oral administration: interaction with the transporters on Caco-2 cells.
    Katragadda S; Jain R; Kwatra D; Hariharan S; Mitra AK
    Int J Pharm; 2008 Oct; 362(1-2):93-101. PubMed ID: 18638532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of acyclovir after intravenous infusion of acyclovir and after oral administration of acyclovir and its prodrug valacyclovir in healthy adult horses.
    Garré B; Shebany K; Gryspeerdt A; Baert K; van der Meulen K; Nauwynck H; Deprez P; De Backer P; Croubels S
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4308-14. PubMed ID: 17846132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel nonsteroidal compounds as substrates or inhibitors of hASBT.
    Kolhatkar V; Diao L; Acharya C; Mackerell AD; Polli JE
    J Pharm Sci; 2012 Jan; 101(1):116-26. PubMed ID: 22109685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailoring acyclovir prodrugs with enhanced antiviral activity: rational design, synthesis, human plasma stability and in vitro evaluation.
    Chayrov RL; Stylos EK; Chatziathanasiadou MV; Chuchkov KN; Tencheva AI; Kostagianni AD; Milkova TS; Angelova AL; Galabov AS; Shishkov SA; Todorov DG; Tzakos AG; Stankova IG
    Amino Acids; 2018 Aug; 50(8):1131-1143. PubMed ID: 29779181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.